Lupin Limited has obtained approval from the USFDA for its 150 mg, 300 mg, and 600 mg strength Oxcarbazepine ER tablets.
Servier India, the Indian subsidiary of French multinational pharmaceutical company Servier Group, has rolled out Ivosidenib, an oral targeted treatment for IDH1-mutated acute myeloid leukaemia
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price ceilings on 41 combinations of drugs, including 18 types of Boehringer Ingelheim's
Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...
Amid the renewed surge in Covid-19 cases across the country, Andhra Pradesh Information and Public Relations Minister K Parthasarathi on Sunday called on citizens to stay alert and follow precautionary guidelines...
U.S. Health Secretary Robert F. Kennedy Jr. declared that COVID-19 vaccines would no longer be routinely recommended for pregnant women and healthy children, bypassing the CDC’s standard advisory process...
After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...
A panel of advisers to the U.S. Food and Drug Administration (FDA) unanimously recommended that COVID-19 vaccines for the 2025–26 season target updated strains of the JN.1 variant, and particularly...
FedEx Corp. (NYSE: FDX) has gained recognition from the International Air Transport Association (IATA) through its CEIV Pharma Corporate Certification which values its strong commitment to handling pharmaceuticals well across the world...
India’s Implant Market to Reach USD 5 Billion by FY28 on Strong DemandIndia's orthopaedic and cardiac implant industry is likely to grow to USD 4.5–5 billion by FY2027-28, almost twice the size it is today at USD 2.4–2.7 billion in FY24...